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DISCUSSION

CASE REPORT
INTRODUCTION

Comprising the most extensive component
of the human lymphatic system, mucosaassociated lymphoid tissue (MALT)
is a protective system of extra-nodal
lymphoid cells distributed throughout
1
the body. Malignancies that develop
within these tissues are regarded as
extra-nodal marginal zone lymphoma
of mucosa-associated lymphoid tissue
(MALT lymphoma) and represent about
2,3
8% of all non-Hodgkin lymphomas.
Most MALT lymphomas develop within
the stomach and have been associated
with chronic inflammation from infectious
3
or autoimmune etiologies. Fewer than
30% are noted to arise from within the
3
small intestine. Helicobacter pylori (H.
pylori) has been a well described risk
factor for the development of gastric MALT
lymphomas, however it’s role in duodenal
disease is unclear as only a limited
4
number or reports have been described.
We present a unique case in which a
MALT lymphoma, discovered within the
duodenum, developed from a duodenal
ulcer in the absence of autoimmune or
infectious causes.

A 56-year-old male with a medical history of hypertension presented to his primary care doctor for
evaluation of progressive fatigue and melena over the previous few weeks. Laboratory data revealed a
microcytic anemia with a hemoglobin of 6.6 g/dL. Initial upper endoscopy revealed a large white based
non-bleeding ulcer with heaped edges within the second portion of the duodenum (Figure 1). Duodenal
biopsies revealed active chronic duodenitis with evidence of gastric metaplasia. Antral biopsies were
performed and H.pylori staining was negative. Computed tomography of the abdomen and pelvis revealed
wall-thickening of the junction of the second and third portions of the duodenum. He was started on a
proton pump inhibitor. Follow up endoscopy 3 months later revealed persistence of the duodenal lesion
with a new nodularity component (Figure 2). Repeat biopsy was consistent with a MALT lymphoma (Figure
3). Follow up positron emission tomography (PET) scan and bone marrow biopsy revealed stage 1E
disease without evidence of lymph node involvement or metastasis. He completed 4 cycles of rituximab
therapy with follow up PET scan revealing partial tumor regression.

•	Primary duodenal MALT lymphoma is exceedingly rare with a small number of case reports 1995

4

•	Symptoms of gastrointestinal MALT Lymphoma are dependent on location of growth however may include:
			–
			–
			–
			–

Indigestion, abdominal pain
Night sweats, weight loss, low grade fevers
Iron deficiency anemia, melena
Constipation and even bowel obstruction in severe cases

•	Diagnosis is made endoscopically with biopsies revealing:
			– Massive lymphomatous infiltration of CD20+ neoplastic cells within lymphoid follicles5

•	The role of autoimmune diseases and H. pylori has been clearly established in gastric disease however is
unclear in duodenal manifestations.
			– F
 ew studies have reported regression following treatment in H. pylori positive cases6
			– Few studies have reported remission with combination chemotherapy including CVP (cyclophosphamide,
3,8
vincristine, and prednisolone) and rituximab

•	In our case report, we have presented the progression of a duodenal ulceration to a MALT lymphoma
			– Duodenal ulcerations in itself may represent a significant risk factor for MALT lymphoma development

•	Clinical experience and judgment is crucial in its diagnosis. Although duodenal ulceration does not currently
require follow up endoscopy, unusual or atypical appearing lesions should always be investigated with biopsy
and followed clinically for resolution.
Figure 1: Initial EGD revealing a large white based ulcer with heaped edges
within the second portion of the duodenun.

Figure 2: Repeat Endoscopy 3months later revealing development of duodenal
lesion with nodularity component.

Figure 3: Endoscopic biopsy of duodenal mass revealing dense infiltration of glandular tissue by
lymphoid neoplastic cells.
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